8
Participants
Start Date
December 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
August 31, 2012
Elevation of FFA during OGTT
"0-240 min: Intralipid® 20%, Pharmacia AB, Stockholm, Sweden, 90 ml/hr; Heparin Immuno®, Immuno AG, Vienna, Austria, bolus: 200IU, continuous infusion: 0.2 IU.kg-1.min-1"
Elevation of FFA during Clamp
"0-240 min: Intralipid® 20%, Pharmacia AB, Stockholm, Sweden, 90 ml/hr; Heparin Immuno®, Immuno AG, Vienna, Austria, bolus: 200IU, continuous infusion: 0.2 IU.kg-1.min-1."
Medical University Vienna, Vienna
Lead Sponsor
Medical University of Vienna
OTHER
German Diabetes Center
OTHER